Ascenion is an independent technology transfer company focussing on the life sciences.

We work closely with 25 European public research institutions to ensure that promising scientific findings are identified, secured and brought to market to the benefit of society.

On average, we evaluate 120 invention disclosures per year, handle 60 patent applications and negotiate some 40 revenue-generating cooperation and licensing agreements with industry. Moreover, we guide and support spin-offs on the road to independence.

Currently, we hold equity in over 30 of these companies. All this helps create innovative products and jobs in growths sectors.

We offer access to more than 500 commercial opportunities. The portfolio includes potential therapeutics and diagnostics addressing a broad range of diseases, as well as medical device technologies, platform technologies and software.